BellBrook

Enzolution eIF4A3 ATPase FP Assay System

As low as CHF 0.00
In stock
Only %1 left
BBL-3056-FP-1K1000 assaysCHF 571.00
BBL-3056-FP-10K10000 assaysCHF 3’886.00
BBL-3056-FP-100K10 x 10000 assaysINQ
NEW

Specifications / Handling

More Information
Product Details
Synonyms Eukaryotic Initiation Factor 4A-III; DDX48; ATP-dependent RNA Helicase eIF4A-3; Nuclear Matrix Protein 265
Product Type Kit
Properties
Application Set Compound Screening
Crossreactivity Human
Quantity

1000 assays/384wells (BBL-3056-FP-1K)

10000 assays/384wells (BBL-3056-FP-10K)

100000 assays/384wells (BBL-3056-FP-100K)

Note: The exact number of assays depends on enzyme reaction conditions.

Detection Type Fluorescent polarization
Kit Contains

- eIF4A3 (human) (rec.) (His) Enzyme
- Yeast RNA (10mg/μl)
- Enzyme Assay Buffer E, 10X
- TCEP, 0.5M 
- 384-Well Low Volume Assay Plates (Corning#4514; sold under #BBL-2229 or BBL-2230)

Other Product Data

Click here for Complete Information from the Original Manufacturer
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by BellBrook Labs.
Accession Number P38919
Shipping and Handling
Shipping DRY ICE
Short Term Storage -20°C
Long Term Storage -20°C
Handling Advice Avoid freeze/thaw cycles.
Documents
Manual Download PDF Download PDF
Product Specification Sheet
Datasheet Download PDF Download PDF

Scientific Background Information

Product Description

The Enzolution EIF4A3 ATPase Assay System is intended for use with the Transcreener® ADP2 Assay Kits to measure the RNA-dependent ATPase activity of EIF4A3 (eukaryotic initiation factor 4A-III), a member of the DEAD-box family of RNA helicases (DDX48). EIF4A3 is a key core factor of the exon junction complex (EJC), a splicing-dependent multiprotein assembly that is deposited on mRNAs at splice junctions. ADP formation by EIF4A3 can be easily measured with the Transcreener ADP2 assay, a far-red, competitive fluorescence assay that enables single addition, mix-and-read detection in a continuous or endpoint format. The assay has been optimized and extensively validated for high-throughput screening (HTS) and inhibitor dose-response measurements using most multimode plate readers.

The Enzolution EIF4A3 ATPase Assay System provides all reagents required to screen and profile EIF4A3 inhibitors, including purified, full-length human EIF4A3 and yeast RNA, when used with the Transcreener ADP2 Assay Kits, which are available with FP, FI and TR-FRET readouts. The protocol is configured for 384-well plates; use of different multi-well plate formats will require adjustment of reagent concentrations utilized in the assay.

When purchasing the eIF4A3 ATPase FP Assay System, it is important to choose the assay system readout corresponding to the FP configuration of your Transcreener ADP2 Assay Kit!

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.